106 related articles for article (PubMed ID: 17875786)
1. Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer.
DeRosier LC; Buchsbaum DJ; Oliver PG; Huang ZQ; Sellers JC; Grizzle WE; Wang W; Zhou T; Zinn KR; Long JW; Vickers SM
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5535s-5543s. PubMed ID: 17875786
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts.
Tamura K; Takada M; Kawase I; Tada T; Kudoh S; Okishio K; Fukuoka M; Yamaoka N; Fujiwara Y; Yamakido M
Jpn J Cancer Res; 1997 Feb; 88(2):218-23. PubMed ID: 9119752
[TBL] [Abstract][Full Text] [Related]
3. Biological impact and therapeutic potential of a novel camptothecin derivative (FLQY2) in pancreatic cancer through inactivation of the PDK1/AKT/mTOR pathway.
Wang W; Xiong H; Li L; Hu X; Zhuang W; Li J; Sun X; Yu Y; Yu Y; Guo Y; Wang Y; Wang R; Wang H; Li Q
Bioorg Chem; 2024 May; 148():107436. PubMed ID: 38735265
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells.
Wang J; Zhang X; Ma D; Lee WP; Xiao J; Zhao Y; Go VL; Wang Q; Yen Y; Recker R; Xiao GG
Exp Hematol Oncol; 2013; 2():18. PubMed ID: 23890079
[TBL] [Abstract][Full Text] [Related]
5. Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox.
Lim B; Greer Y; Lipkowitz S; Takebe N
Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31370269
[No Abstract] [Full Text] [Related]
6. A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models.
Kim H; Buchsbaum DJ; Zinn KR
Mol Imaging Biol; 2016 Jun; 18(3):325-33. PubMed ID: 26552657
[TBL] [Abstract][Full Text] [Related]
7. Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo.
Kimbrough CW; Khanal A; Zeiderman M; Khanal BR; Burton NC; McMasters KM; Vickers SM; Grizzle WE; McNally LR
Clin Cancer Res; 2015 Oct; 21(20):4576-85. PubMed ID: 26124201
[TBL] [Abstract][Full Text] [Related]
8. Orthotopic pancreatic tumors detected by optoacoustic tomography using Syndecan-1.
Kimbrough CW; Hudson S; Khanal A; Egger ME; McNally LR
J Surg Res; 2015 Jan; 193(1):246-54. PubMed ID: 25439222
[TBL] [Abstract][Full Text] [Related]
9. Toxic effects of xylazine on endothelial cells in combination with cocaine and 6-monoacetylmorphine.
Silva-Torres LA; Vélez C; Lyvia Alvarez J; Ortiz JG; Zayas B
Toxicol In Vitro; 2014 Oct; 28(7):1312-9. PubMed ID: 25017475
[TBL] [Abstract][Full Text] [Related]
10. Targeting apoptosis signaling in pancreatic cancer.
Fulda S
Cancers (Basel); 2011 Jan; 3(1):241-51. PubMed ID: 24212616
[TBL] [Abstract][Full Text] [Related]
11. Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis.
Qiu W; Su GH
Cancer Metastasis Rev; 2013 Jun; 32(1-2):83-107. PubMed ID: 23114842
[TBL] [Abstract][Full Text] [Related]
12. Micro-ultrasound for preclinical imaging.
Foster FS; Hossack J; Adamson SL
Interface Focus; 2011 Aug; 1(4):576-601. PubMed ID: 22866232
[TBL] [Abstract][Full Text] [Related]
13. Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
Kim H; Zhai G; Samuel SL; Rigell CJ; Umphrey HR; Rana S; Stockard CR; Fineberg NS; Zinn KR
Mol Cancer Ther; 2012 Feb; 11(2):405-15. PubMed ID: 22203731
[TBL] [Abstract][Full Text] [Related]
14. Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
Oliver PG; LoBuglio AF; Zhou T; Forero A; Kim H; Zinn KR; Zhai G; Li Y; Lee CH; Buchsbaum DJ
Breast Cancer Res Treat; 2012 Jun; 133(2):417-26. PubMed ID: 21901385
[TBL] [Abstract][Full Text] [Related]
15. Molecular targeted approaches for treatment of pancreatic cancer.
Huang ZQ; Saluja AK; Dudeja V; Vickers SM; Buchsbaum DJ
Curr Pharm Des; 2011; 17(21):2221-38. PubMed ID: 21777178
[TBL] [Abstract][Full Text] [Related]
16. Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy.
Kim H; Zhai G; Liu Z; Samuel S; Shah N; Helman EE; Knowles JA; Stockard CR; Fineberg NS; Grizzle WE; Zhou T; Zinn KR; Rosenthal EL
Anticancer Drugs; 2011 Oct; 22(9):864-74. PubMed ID: 21730821
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo.
Canu B; Fioravanti A; Orlandi P; Di Desidero T; Alì G; Fontanini G; Di Paolo A; Del Tacca M; Danesi R; Bocci G
Neoplasia; 2011 Mar; 13(3):217-29. PubMed ID: 21390185
[TBL] [Abstract][Full Text] [Related]
18. Combined modality therapy with TRAIL or agonistic death receptor antibodies.
Amm HM; Oliver PG; Lee CH; Li Y; Buchsbaum DJ
Cancer Biol Ther; 2011 Mar; 11(5):431-49. PubMed ID: 21263219
[TBL] [Abstract][Full Text] [Related]
19. Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition.
Bodenstine TM; Vaidya KS; Ismail A; Beck BH; Cook LM; Diers AR; Landar A; Welch DR
Cancer Res; 2010 Dec; 70(23):10002-11. PubMed ID: 21098703
[TBL] [Abstract][Full Text] [Related]
20. KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.
McNally LR; Welch DR; Beck BH; Stafford LJ; Long JW; Sellers JC; Huang ZQ; Grizzle WE; Stockard CR; Nash KT; Buchsbaum DJ
Clin Exp Metastasis; 2010 Dec; 27(8):591-600. PubMed ID: 20844932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
